Feinstein Institutes Awarded $11.3M Subcontract for COVID-19 Antibody Research
November 05, 2020
November 05, 2020
MANHASSET, New York, Nov. 5 (TNSAwa) -- Feinstein Institutes for Medical Research issued the following news:
The Feinstein Institutes for Medical Research has been awarded a multi-year subcontract from The Frederick National Laboratory for Cancer Research (FNL), currently operated by Leidos Biomedical Research, Inc. for the National Cancer Institute (NCI), to establish a Capacity Building Center (CBC) to further develop and deploy serological (antibody) testing assays for the novel . . .
The Feinstein Institutes for Medical Research has been awarded a multi-year subcontract from The Frederick National Laboratory for Cancer Research (FNL), currently operated by Leidos Biomedical Research, Inc. for the National Cancer Institute (NCI), to establish a Capacity Building Center (CBC) to further develop and deploy serological (antibody) testing assays for the novel . . .